5-LOX-IN-2
5-LOX-IN-2, an inhibitor of 5-lipoxygenase (5-LOX) with an IC50 of 0.33 μM, inhibits 5-LOX in a dose-dependent manner . 5-LOX-IN-2, reduces the cell viability of renal cancer cells and induces apoptosis, can be used for cancer research[1].
Product Specifications
CAS Number
[179691-97-5]
UNSPSC
12352005
Target
Lipoxygenase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/5-lox-in-2.html
Purity
98.75
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(OCCC1=CC=CC=C1)/C=C/C2=CC(O)=CC=C2O
Molecular Formula
C17H16O4
Molecular Weight
284.31
References & Citations
[1]Selka A, et.al. Discovery of a novel 2,5-dihydroxycinnamic acid-based 5-lipoxygenase inhibitor that induces apoptosis and may impair autophagic flux in RCC4 renal cancer cells. Eur J Med Chem. 2019 Oct 1;179:347-357.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
5-LOX
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL700727V 500 µL Each
Mrpl34 Rat shRNA Lentiviral Particle (Locus ID 290632)
Sign In for Pricing
View Details 
MBS6197478-01 0.1 mL
PTPN4 (Protein Tyrosine Phosphatase, non-Receptor Type 4 (megakaryocyte), PTPMEG, PTPMEG1) (MaxLight 405)
Sign In for Pricing
View Details 
MBS6197478-02 5x 0.1 mL
PTPN4 (Protein Tyrosine Phosphatase, non-Receptor Type 4 (megakaryocyte), PTPMEG, PTPMEG1) (MaxLight 405)
Sign In for Pricing
View Details